Back to Dashboard
SOLV · Healthcare

Solventum Corp

USA Healthcare Filing: 2026-03-31
28/100
Smart-money confidence1 of 3 sources positive
Weak — few signals

No standout activity across the feeds we track.

Hedge funds
38
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$15.1B
Industry
Medical Instruments & Supplies
Sector
Healthcare
Exchange
NYSE
About SOLVENTUM CORP

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes,…

Who's behind the signal
Every informed buyer we can see on SOLV, across all three feeds.
Hedge funds · 7
Citadel Advisors Increased +431%
AQR Capital Management Increased +56%
D.E. Shaw & Co Decreased −26%
+1 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar. SOLVENTUM CORP isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
0
New positions
4
Increasing
2
Decreasing
1
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.1×
Increased +114%
% of portfolio
0.1%
Position change
+114%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
Increased +431%
% of portfolio
0.0%
Position change
+431%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
Increased +9%
% of portfolio
0.0%
Position change
+9%
0.0% of Millennium Management's portfolio
Trust weight: 1.0×
Increased +56%
% of portfolio
0.0%
Position change
+56%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.1×
Unchanged
% of portfolio
1.9%
Position change
1.9% of Davis Selected Advisers's portfolio
Trust weight: 1.0×
Decreased −26%
% of portfolio
0.0%
Position change
−26%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.3×
Decreased −75%
% of portfolio
0.0%
Position change
−75%
0.0% of Bridgewater Associates's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to SOLVENTUM CORP
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell SOLVENTUM CORP or any security.

订阅每周更新

我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费,直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订